Ondansetron HCL 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQJTX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,586
Award facts
- Contract value 100% obligated
- $20,585.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ondansetron HCL 4 mg tablets (30-count) with a ceiling value of $20,585.73. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion deadline of September 17, 2025. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support agreement running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying a wide range of pharmaceutical products including generic and brand-name medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The underlying IDC with DLA Troop Support Medical enables the company to provide global pharmaceutical support to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Ondansetron, an antiemetic medication commonly used in medical settings, represents one component of AmerisourceBergen's ongoing pharmaceutical supply obligations to support federal military and healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQJTX?
SPE2DB25FQJTX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FQJTX worth?
The government has obligated $20,586 on SPE2DB25FQJTX.
Is contract SPE2DB25FQJTX an order under another contract?
Yes. SPE2DB25FQJTX is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJTX competed?
The extent of competition for SPE2DB25FQJTX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award